Nishikawa M - Search Results

1

Anti-aldosteronergic effect of torasemide.

Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M. Uchida T, et al. Among authors: nishikawa m. Eur J Pharmacol. 1991 Nov 26;205(2):145-50. doi: 10.1016/0014-2999(91)90812-5. Eur J Pharmacol. 1991. PMID: 1812004

2

AE0047, a new dihydropyridine Ca2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries.

Okamura T, Nishikawa M, Yoshida K, Toda N. Okamura T, et al. Among authors: nishikawa m. Eur J Pharmacol. 1992 Sep 10;220(1):27-33. doi: 10.1016/0014-2999(92)90007-q. Eur J Pharmacol. 1992. PMID: 1385179

3

FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.

Morimoto H, Murai M, Maeda Y, Yamaoka M, Nishikawa M, Kiyotoh S, Fujii T. Morimoto H, et al. Among authors: nishikawa m. J Pharmacol Exp Ther. 1992 Jul;262(1):398-402. J Pharmacol Exp Ther. 1992. PMID: 1378096

4

Pharmacologic profiles of GA0113, a novel quinoline derivative angiotensin II AT1-receptor antagonist.

Ebisu H, Nishikawa M, Tanaka M, Okazoe T, Morizawa Y, Shinyama H, Nakamura N. Ebisu H, et al. Among authors: nishikawa m. J Cardiovasc Pharmacol. 1999 Oct;34(4):526-32. doi: 10.1097/00005344-199910000-00008. J Cardiovasc Pharmacol. 1999. PMID: 10511127

5

Calcium channel blocking and vasodilating actions of the novel dihydropyridine derivative AE0047.

Nishikawa M, Gohda M, Shinyama H, Matzno S, Yamanaga K, Kido H, Nakamura N. Nishikawa M, et al. Clin Exp Pharmacol Physiol. 1998 May;25(5):347-54. doi: 10.1111/j.1440-1681.1998.tb02362.x. Clin Exp Pharmacol Physiol. 1998. PMID: 9612662

6

Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats.

Nishikawa M, Kubo Y, Kido H, Nakayama T, Nakamura N. Nishikawa M, et al. Gen Pharmacol. 1999 Mar;32(3):299-305. doi: 10.1016/s0306-3623(98)00180-3. Gen Pharmacol. 1999. PMID: 10211583

7

Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals.

Sato Y, Nishikawa M, Shinkai H, Sukegawa E. Sato Y, et al. Among authors: nishikawa m. Diabetes Res Clin Pract. 1991 Apr;12(1):53-9. doi: 10.1016/0168-8227(91)90130-6. Diabetes Res Clin Pract. 1991. PMID: 1906797

8

Effects of actinomycin D on airway constriction induced by tachykinins and capsaicin in guinea-pigs.

Fujii T, Murai M, Morimoto H, Nishikawa M, Kiyotoh S. Fujii T, et al. Among authors: nishikawa m. Eur J Pharmacol. 1991 Mar 5;194(2-3):183-8. doi: 10.1016/0014-2999(91)90103-w. Eur J Pharmacol. 1991. PMID: 1711981

9

Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.

Murai M, Morimoto H, Maeda Y, Kiyotoh S, Nishikawa M, Fujii T. Murai M, et al. Among authors: nishikawa m. J Pharmacol Exp Ther. 1992 Jul;262(1):403-8. J Pharmacol Exp Ther. 1992. PMID: 1378097

10

Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism.

Takakura Y, Masuda S, Tokuda H, Nishikawa M, Hashida M. Takakura Y, et al. Among authors: nishikawa m. Biochem Pharmacol. 1994 Mar 2;47(5):853-8. doi: 10.1016/0006-2952(94)90485-5. Biochem Pharmacol. 1994. PMID: 8135860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results